United States Skin Boosters Market Insights Forecasts to 2033

• The U.S. Skin Boosters Market Size was valued at USD 360.5 Million in 2023.
• The Market Size is Growing at a CAGR of 8.57% from 2023 to 2033
• The U.S. Skin Boosters Market Size is Expected to reach USD 820.5 Million by 2033

The United States Skin Boosters Market Size is anticipated to Exceed USD 820.5 Million by 2033, Growing at a CAGR of 8.57% from 2023 to 2033. The Growing need for cosmetic procedures, rising government approvals, and ongoing research and innovation in the cosmetic industry are driving the Growth of the skin boosters Market in the US.     

Market Overview

Skin boosters are cosmetic injectables intended to enhance the moisture, elasticity, and general appearance of the skin. Typically, they include hyaluronic acid, which is a chemical that the body naturally produces and aids in moisture retention and skin health. Customers are looking for minimally invasive procedures with short recovery times that produce outcomes that look natural. Skin boosters meet this requirement by improving the texture and brightness of the skin gradually and permanently. Technological development in dermatology including aesthetic medicine and the creation of innovative medicine with better formulations and delivery methods result in improved patient outcomes and increased patient satisfaction.     

Report Coverage

This research report categorizes the market for the US skin boosters market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States skin boosters market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the US skin boosters market.

Driving Factors

In 2023, there was a notable 5% growth in the demand for plastic surgery, image enhancement procedures, and other cosmetic procedures, according to a recent report by the American Society of Plastic Surgeons. Thus, the increasing demand for cosmetic procedures is driving the market demand. Technological advancements drive innovation, resulting in the development of new delivery systems and formulations that enhance efficacy and patient comfort. The increased emphasis on R&D and the development of innovative products drive market growth. Further, the government approval for new products in the cosmetic industry is propelling the market.      

Restraining Factors

The high price of skin booster treatments may prevent some customer groups from using them. In addition, cosmetic injectable safety and regulatory problems are still under investigation and could hinder market expansion.

Market Segmentation

The United States Skin Boosters Market share is classified into type, gender, and end-use.

• The mesotherapy segment dominates the market with the largest market share during the forecast period.

The United States skin boosters market is segmented by type into mesotherapy and micro-needle. Among these, the mesotherapy segment dominates the market with the largest market share during the forecast period. Mesotherapy is a versatile treatment for a wide range of skin disorders since it may be used to treat a large number of skin care issues. This therapy is preferable over microneedle treatment as it usually requires less recuperation time for patients. In addition, the deeper layers of the skin can receive customized hydration with the use of small injections of hyaluronic acid, vitamins, and minerals. The increasing prevalence of COPD in the country is responsible for driving the market demand.

• The female segment accounted for the largest revenue share of the US skin boosters market in 2023.

The United States skin boosters market is segmented by gender into male and female. Among these, the female segment accounted for the largest revenue share of the US skin boosters market in 2023. Acne, pigmentation, and dullness are all common skin conditions among women. Acne is most common in women between the ages of 14 and 17, with adolescent acne affecting 79-82% of young women. Further, the increasing preference for anti-aging techniques majorly among the female population is driving the market demand.

• The medical spa segment is expected to register the fastest CAGR growth during the forecast period.       

Based on the end-use, the U.S. skin boosters market is divided into medical spa and dermatology clinics. Among these, the medical spa segment is Expected to register the fastest CAGR growth during the forecast period. Skin booster operations are primarily performed by medspas due to the minimum patient downtime and non-invasive nature of cosmetic surgery. The increased number of medical spas as well as the rising spending on medical spas by the patients in the country is responsible for driving the market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the U.S. skin boosters market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

List of Key Companies

• Bloomage Biotech Co., Ltd.
• Medytox, Inc.
• Merz Pharma
• Galderma
• Teoxane
• AbbVie Inc.
• IBSA Farmaceutici Italia Srl
• PharmaResearch Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In January 2024, AbbVie strengthened its manufacturing capabilities by breaking ground on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment would add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network.

• In May 2023, Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of SKINVIVE by JUVÉDERM to improve skin smoothness of the cheeks in adults over the age of 21.

Market Segment

This study forecasts revenue at U.S., regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United States Skin Boosters Market based on the below-mentioned segments:

US Skin Boosters Market, By Type

• Mesotherapy
• Micro-Needle

US Skin Boosters Market, By Gender

• Male
• Female

US Skin Boosters Market, By End-Use

• Medical Spa
• Dermatology Clinics